News|Articles|September 29, 2026 (Updated: October 21, 2026)

Six Years After Leukemia, He Is Rebuilding the Life Cancer Changed at 21

Author(s)Kaitlyn M. Le
Listen
0:00 / 0:00

Key Takeaways

  • Acute presentation with B-cell ALL and concurrent staph infection led to rapid functional decline, loss of autonomy, and early integration of psychotherapy plus pharmacotherapy to manage anxiety and depression.
  • Chemo-refractory disease required CAR-T cell therapy to achieve MRD-negative remission, but two subsequent relapses interrupted reintegration and precipitated allogeneic stem cell transplantation with a matched sibling donor.
SHOW MORE

After two relapses, CAR-T cell therapy, immunotherapy and a stem cell transplant, William Yank's cancer is in remission, where he navigates a new reality shaped by infertility, mental health challenges and a changed sense of self.

He was at work when the call arrived, his phone trembling insistently atop his desk. After he worked up the courage to bring it to his ear, a voice from the fertility clinic confirmed the fear that had been knotted in his stomach.

“Nothing, absolutely nothing? You’re telling me there’s not even a surprise?” William Yank recalled asking.

Starting at 21, Yank underwent chemotherapy, CAR T-cell therapy, immunotherapy and a stem cell transplant for cancer that relapsed twice. At the time, his only goal was to survive.

Years later, the call came from a fertility clinic. His test showed no viable sperm.

Yank had returned to school, graduated and built a career. Although cancer no longer consumed his time, the result revealed one of its many lasting effects. Treatment had taken away a choice he hadn’t yet made, one he had assumed would still be his. It became another part of cancer he would have to navigate long after treatment ended.

Yank began working through what the result meant for future relationships and how it shaped the way he saw himself.

“I’m not damaged goods. I have plenty to offer,” he said. “But I can view aspects of my life as though I’m damaged.”

Six years into remission, Yank is still working through those questions, part of the longer process of rebuilding a life that changed within days when he was 21.

Before Cancer, He Felt ‘On Cloud 11’

The summer after his junior year of college, Yank moved to Washington, D.C., for a competitive internship on Capitol Hill.

He was a full-time student majoring in English literature and business, had signed a modeling contract and was making YouTube videos. He also competed in the triple jump, long jump and high jump for his college track team.

“There’s cloud nine, and there’s cloud 11. I was on cloud 11,” Yank said. “I was super excited about life when I was 21.”

One night, he noticed a sudden pain in the joints of his hands. He brushed it off. He was young and healthy. What could be wrong?

Over the next few weeks, Yank could no longer keep up with friends on runs and in workouts. Then a severe sore throat sent him to urgent care, where he was told he had mononucleosis.

As his throat swelled, he could eat only foods soft enough to swallow. He grew weaker by the day, until even getting a glass of water was a struggle. One day, too weak to open the refrigerator door, he collapsed. His roommate found him on the floor and rushed him to the emergency room.

There, doctors found what was really wrong: B-cell acute lymphoblastic leukemia (ALL), a cancer of the blood and bone marrow, along with a serious staph infection.

“I was so sick,” he said. “I was experiencing organ failure. Organs were shutting down.”

Within days, the life he had been building gave way to hospital rooms, treatment and uncertainty about what came next.

From Track Competition to Physical Therapy in Bed

Yank was transferred to Johns Hopkins Hospital in Baltimore and began chemotherapy the next day. He considers those first weeks the most physically difficult part of his treatment.

Fluid retention caused him to gain approximately 50 to 60 pounds in a short period. When his nurses tried to help him stand, he sometimes passed out. Physical therapy began from his hospital bed. For someone who had been running, training and competing on a college track team a few weeks earlier, the sudden loss of strength was difficult to process.

“My entire identity was shifting and changing,” he said.

His mother, who worked at a mental health clinic, connected him with a therapist early in his treatment, while his care team started him on medication for anxiety and depression. As his treatment continued, Yank said some of the hardest moments came from losing his privacy and control over his own body.

At times, he asked his mother to have everyone leave so he could have space to cry alone. Weekly phone calls with his therapist gave him somewhere to process the fear, frustration and changes to his identity rather than push them aside.

“This cancer was staying with me,” Yank said. “This isn’t a flu. This isn’t bronchitis that’ll go away after a while.”

Each Remission Let Him Start Living Again

When chemotherapy did not completely clear the leukemia, Yank underwent CAR-T cell therapy, which utilizes modified immune cells to recognize and attack cancer.

The treatment brought him into remission, and for about six months, tests showed no measurable residual disease, meaning no leukemia could be detected at the level being measured. During that time, Yank began returning to parts of the life he had before treatment, until the leukemia returned.

“The first relapse, I was like, OK, we’ve done this once, we can do it again,” he said.

A second CAR-T cell infusion led to another remission. In the months that followed, Yank began preparing to return to college. After spending much of his life centered on hospitals and treatment, he moved back to campus and started classes, beginning to settle into a routine again.

Two weeks into the semester, the leukemia returned for a second time.

“I was back into life and then had it just torn back away again,” he said.

This time, his treatment options were becoming more limited. Before the transplant, Yank received the immunotherapy Blincyto (blinatumomab), a bispecific T cell engager that helps the body's T cells find and attack leukemia cells. His oncologist told him they would need to move forward with a stem cell transplant, and his older sister would be his donor.

“OK, this is the real deal,” Yank said. “This is going to determine a lot of my future.”

Cancer Made Him Plan for the Future

When Yank was first diagnosed, fertility preservation was not something he or his family had time to consider. He was critically ill and needed treatment immediately. Before a later round of treatment, his oncology team raised the option of preserving sperm, around the same time he was completing an advance directive outlining what he wanted to happen if he died.

He was still in his early 20s, without a spouse or children, making decisions about death while also trying to preserve the possibility of one day having a family.

“I feel young to be making this decision,” Yank said. “What does that mean for my future spouse and partner in my relationships?”

The fertility result also shaped how he approached dating and future relationships. Although Yank is open about his infertility within the first few dates, telling someone that having children may not be possible for him remains a difficult conversation.

“If this is something that you would like to do, if you would like to have kids naturally, I’m not your person,” he said.

Yank does not blame those who have seen his infertility as a deal breaker. Still, understanding their decision has not always made rejection easier or protected his sense of self-worth. In therapy, he has worked through how it changed the way he views himself and what he believes he can offer a future partner.

What does recovery mean six years after B-cell ALL?

Six years after entering remission, Yank now works full time in investment operations and client service, while mental health remains one of the areas he continues to navigate. He still takes medication for anxiety and depression and recently had a morning when he could not get out of bed and was late to work. He said being open about those moments helps show what survivorship can still look like years later.

“It’s worthy to pursue a career. It’s worthy to pursue a dream. It’s worthy to pursue a relationship still, even though it may not be what I thought it would look like before I got sick,” he said.

As a former track athlete, he once centered exercise on training and performance. Now, he approaches his physical health differently by focusing on what he can maintain, whether that is yoga, walking, getting his steps in or squeezing in a short workout after work.

"You're not invincible" are the first words Yank would say to the 21-year-old version of himself, before the hospital stays, relapses and years of treatment.

Cancer at a young age gave Yank an earlier awareness of mortality and changed how he moves through life and thinks about what is still ahead.

“You’re gonna make it,” he said. “But just make sure you stay open to learning along the way and stay curious.”

For more news on cancer updates, research and education, don't forget to subscribe to CURE®'s newsletters here.



Related to this article

Image of Pancreas
Rasonque (daraxonrasib), the first approved drug to directly target RAS in pancreatic cancer, nearly doubled survival in a key trial. Two patients, a caregiver and the professionals who care for people like them explain what it means to live with the disease.